Skip to main content
Equibles

NEULANDLAB · Neuland Laboratories Limited

Use NEULANDLAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NEULANDLAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
21,081.70 INR +165.10 (+0.79%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 2274 Avg daily vol (3M) 3236

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close21,081.70 INR Open20,947.45 INR Day20,793.25–21,704.50 INR 52W close11,549.75–23,973.6992 INR Avg vol 30d3K Last earningsNov 3, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Nov 3
Earnings call
Quarterly earnings declined despite H1FY27 revenue growth

Neuland Laboratories Limited posted Q2 total income of Rs.457.2 Crores, EBITDA of Rs.104.6 Crores and profit after tax of Rs.51.1 Crores; H1FY27 total income was Rs.1107.2 Crores, while input costs increased.

5 source passages
Neuland Laboratories Limited’s Q2 and H1 FY27 Earnings Conference Call. The total income for the quarter stood at Rs.457.2 Crores compared to Rs.516.1 Crores in the corresponding previous last year. For the H1FY27, the total income stood at Rs.1107.2 Crores compared to Rs.816.7 Crores in H1 FY26. EBITDA for the quarter stood at Rs.104.6 Crores, representing a margin of 22.9% compared to Rs.156.9 Crores and a margin of 30.4% during the corresponding period last year. Profit after tax for the quarter was Rs.51.1 Crores compared to Rs.96.5 Crores in Q2 FY2026. During the first half of the financial year, we also experienced increase in input costs. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲1.3% 3.98B INR 0 INR '25 Q3 ▼14.7% 3.28B INR 0 INR '25 Q4 ▼33.4% 2.93B INR 139.00M INR '26 Q1 ▲65.4% 5.14B INR 0 INR '26 Q2 ▲10.5% 4.40B INR 405.72M INR '26 Q3 ▲136.4% 7.76B INR 2.13B INR '26 Q4 ▲119.2% 6.42B INR 1.48B INR '27 Q1 LATEST ▼12.6% 4.50B INR 516.27M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 11,549.75 INR Now 21,081.70 INR · 77% Range high 23,973.6992 INR
vs 200-day avg +19% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:NEULANDLAB +7.0% +5.7% +28.6% +7.0% +38.8%

Exchange listing

Market
XBOM
Ticker
NEULANDLAB
ISIN
INE794A01010
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.neulandlabs.com/
Investor relations
https://www.neulandlabs.com/en/investors/disclosures-under-regulation-46-sebi-listing-regulations

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-07-24 34.00 INR
2025-07-18 12.00 INR
2024-07-12 14.00 INR
2023-07-11 10.00 INR
2022-07-14 5.00 INR
2021-06-29 3.00 INR
2020-11-10 2.00 INR
2020-02-18 2.00 INR
2019-06-27 1.20 INR
2016-08-04 2.00 INR
2015-08-06 1.50 INR
2013-07-24 1.20 INR

Upcoming investor events

DateEventType
2026-11-17 00:00 UTC Schedule of Analyst / Institutional Investor Meeting – November 17, 2026 Event

Earnings calls

  • Earnings call · Q2 2027 2026-11-03 Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-08-05 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-12 Transcript
    Earnings Call for the Quarter Ended March 31, 2026